Table 2. miRNAs by array analysis with significantly different expression levels in non-dysplastic UC tissue 1–2 years prior to developing neoplasia in UC progressors compared to non progressors.
| miRNA | LogFC | P Value |
|---|---|---|
| hsa-miR-363-3p | 0.16 | 0.04 |
| hsa-miR-558 | 0.26 | 0.03 |
| hsa-miR-515-5p | 0.34 | 0.04 |
| hsa-miR-659-3p | 0.35 | 0.05 |
| hsa-miR-4443 | 0.37 | 0.02 |
| hsa-miR-548i | 0.39 | 0.05 |
| hsa-miR-761 | 0.39 | 0.01 |
| hsa-miR-598 | 0.41 | 0.02 |
| hsa-miR-325 | 0.43 | 0.03 |
| hsa-miR-1286 | 0.46 | 0.04 |
| hsa-miR-495 | 0.47 | 0.02 |
| hsa-miR-516a-5p | 0.47 | 0.05 |
| hsa-miR-548w | 0.50 | 0.04 |
| hsa-miR-127-3p | 0.53 | 0.002 |
| hsa-miR-10b-5p | 0.56 | 0.02 |
| hsa-miR-644a | 0.57 | 0.05 |
| hsa-let-7e-5p | 0.64 | 0.03 |
| hsa-miR-144-3p | 1.46 | 0.05 |
| hsa-miR-16-5p | 1.51 | 0.01 |
| hsa-miR-215 | 1.85 | 0.04 |
| hsa-miR-1283 | 1.92 | 0.004 |
| hsa-miR-1246 | 2.15 | 0.04 |
| hsa-miR-4488 | 2.52 | 0.03 |
| hsa-miR-494 | 3.43 | 0.01 |